Cinctive Capital Management LP Astrazeneca PLC Transaction History
Cinctive Capital Management LP
- $1.89 Billion
- Q3 2025
A detailed history of Cinctive Capital Management LP transactions in Astrazeneca PLC stock. As of the latest transaction made, Cinctive Capital Management LP holds 122,521 shares of AZN stock, worth $11 Million. This represents 0.5% of its overall portfolio holdings.
Number of Shares
122,521
Previous 41,974
191.9%
Holding current value
$11 Million
Previous $2.93 Million
220.46%
% of portfolio
0.5%
Previous 0.16%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,498Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...